Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 3Completed 3Withdrawn 1Unknown 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 74INDUSTRY 26OTHER_GOV 3NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Pathologic Complete Response 1

Interventions

Drug Therapy 10pembrolizumab 9Bevacizumab 9Radiotherapy 8Cyclophosphamide 8Carboplatin 8Oxaliplatin 7tislelizumab 6Surgical Procedures, Operative 6Docetaxel 6Cisplatin 6Capecitabine 6Paclitaxel 5Nivolumab 5Fluorouracil 5Control Groups 5fludarabine 4Immune Checkpoint Inhibitors 4Gemcitabine 4Endoscopic Mucosal Resection 4sintilimab 3Trastuzumab 3Pemetrexed 3Neoadjuvant Therapy 3Leucovorin 3Laparoscopy 3Irinotecan 3Injections 3Hematologic Tests 3HMPL-013 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × Trastuzumab × Clear all
NCT07057427 2025-07-09

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Henan Cancer Hospital

Phase 3 Recruiting
812 enrolled
Breast

Breast Neoplasms

NCT06927180 2025-06-23

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Henan Cancer Hospital

Phase 2 Recruiting
180 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

NCT01785420 2025-04-09

Pre Operative Trastuzumab in Operable Breast Cancer

Tata Memorial Hospital

Phase 3 Recruiting
1,100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡